YINGCHI TMS-Advanced Precise Therapy for Autism Spectrum Disorder

ASD is the world's most common childhood mental disorder.

According to statistics in the past 20 years, the global neonatal incidence rate is about 1~2%, and it is increasing year by year.

On December 3rd, Chengdu, China, held a charity activity for children with ASD, "Science and Technology Lights the Stars" on World Disability Day. A comprehensive examination of social disorders, speech disorders, stereotyped behaviors and other problems of children with ASD. The experts applied precision treatment through the world's leading TMS therapy provided by YINGCHI to achieve better results.

More information

Details

Chengdu, Sichuan, China

Shenzhen Yingchi Technology Co.,Ltd.

Associated Trend items

YINGCHI TMS | Welcome to visit us in MEDICA 2023

With over 5,000 exhibitors from 66 countries and more than 81,000 visitors from all over the world, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world.

As an old friend, YINGCHI will once again participate in MEDICA 2023. We are committed to allowing more people to obtain high-quality medical services, and always adheres to independent research and development and technological research.

More information

New research published using YINGCHI TMS

Chinese professional team published their latest research results in "PAIN", a leading journal in the field of pain. In the process of experiment, rTMS stimulation was performed by the YINGCHI FDA-approved M-100 Ultimate.

This study investigates the opioid peptide analgesic mechanism of prolonged continuous theta burst stimulation (pcTBS). The study was a randomized, double-blind, sham-controlled study to reveal whether the endogenous opioid system is involved in the analgesic effects induced by stimulation of the primary motor cortex (M1) and dorsal lateral prefrontal cortex (DLPFC) by i...

More information

YINGCHI M-Ultimate TMS is cleared by FDA for MDD treatment!

We are glad to announce that YINGCHI M-Ultimate transcranial magnetic stimulator has already gained FDA approval this September.

As YINGCHI TMS device gains wider adoption in the medical community, it is expected to play a crucial role in the ongoing battle against depression. This FDA clearance is a testament to YINGCHI’s commitment to developing innovative solutions for mental health challenges. We are dedicated to providing patients with access to safe, non-invasive, and effective treatments fo...

More information

Products associated

TMS + rTMS transcranial magnetic stimulator

M-series

TMS + rTMS transcranial magnetic stimulator

E-series

Compare

Remove all

Compare up to 10 products